HR 11045 119th Congress
To amend the 21st Century Cures Act and the Public Health Service Act to ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.
Latest Action
Referred to the House Committee on Energy and Commerce.
Sponsors
Actions
2026-11-17T00:00:00
Referred to the House Committee on Energy and Commerce.
2026-11-17T00:00:00
Introduced in House
2026-11-17T00:00:00
Introduced in House
![Rep. Gottheimer, Josh [D-NJ-5]](https://bioguide.congress.gov/bioguide/photo/G/G000583.jpg)